What is iRhythm Holdings, Inc. 's R&D?

iRhythm Holdings, Inc. (IRTC) reported R&D of $21.36M in Q1 2026.

How has iRhythm Holdings, Inc. 's R&D changed year-over-year?

iRhythm Holdings, Inc. 's R&D decreased by 0.7% year-over-year, from $21.52M to $21.36M.

What is the long-term trend for iRhythm Holdings, Inc. 's R&D?

Over 4 years (2021 to 2025), iRhythm Holdings, Inc. 's R&D has grown at a 21.6% compound annual growth rate (CAGR), from $38.67M to $84.61M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

iRhythm Holdings, Inc. IRTC R&D

R&D at other companies

Baxter InternationalBAX

$139M-0.7%

ITG

Integer HoldingsITGR

$16.24M+14.4%

Merit Medical SystemsMMSI

$22.61M+0.6%

MedtronicMDT

$671M-1.9%

AbbottABT

$767M+7.1%

CytokineticsCYTK

$95.53M-2.8%

Other financials

Income statement

See full

Revenue$199.4M+25.7%

Gross profit$141.4M+29.4%

Operating income-$16.2M+50.3%

Net income-$13.9M+54.6%

EPS (diluted)-$0.43+55.7%

Balance sheet

See full

Cash & equivalents$248.5M-35.2%

Total debt$79.0M-10.5%

Total equity$161.2M+86.0%

Total assets$1.0B+8.7%

Cash flow

See full

Operating cash flow-$26.2M-232%

CapEx$6.9M-26.7%

Free cash flow-$33.1M-91.1%

Valuation

See full

Market cap$3.62B+16.0%

Profitability

See full

Gross margin71%+1.6pp

Operating margin-5.5%-2.2pp

Net margin-7.3%-3.1pp

FCF margin2.4%—

Returns & leverage

See full

Return on equity-53.1%-17.4pp

Debt / equity0.5×-0.5×

Current ratio5.2×-0.5×

Where this comes from

Reported directly by iRhythm Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's R&D?: iRhythm Holdings, Inc. (IRTC) reported R&D of $21.36M in Q1 2026.
How has iRhythm Holdings, Inc. 's R&D changed year-over-year?: iRhythm Holdings, Inc. 's R&D decreased by 0.7% year-over-year, from $21.52M to $21.36M.
What is the long-term trend for iRhythm Holdings, Inc. 's R&D?: Over 4 years (2021 to 2025), iRhythm Holdings, Inc. 's R&D has grown at a 21.6% compound annual growth rate (CAGR), from $38.67M to $84.61M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.